Furthermore, Van Craenenbroeck et al. reported that preintervention endothelial EVs (CD31+/CD42b) count significantly predicted improvements in VO2max despite no effect of a 12-week training program on these EVs in 200 individuals with coronary artery disease [95]. The gene discussed is PECAM1; the disease is coronary artery disorder.